RE: questions24 Jun 2019 10:57
I agree those are the gripes, concerns and recommendations, but what about the more upbeat questions:
1. When do you think the first commercial monetary success will come?
2. What do you expect the estimated future values are of the compounds?
3. Do you think £2.12 million market cap reflects the current company standings?
4. Do you understand by increasing your personal shareholding, receiving bonuses for achieving commercial (not scientific) milestones and involving sh’s will align sh’s and bod providing confidence to all and remove the them and us type relationship?
5. What is your exit strategy?
6. What is your future marketing strategy and how do you interface with large pharma’s as to many because of VAL’s size you fall below the radar?
7. We hear of junior bio’s moving to commercialisation before P2, do you think 301 is a potential trade sale?
8. Is the FIT bio and 101 JV still on?
Etc